Evidence map›Paper›PMID 20818393›Full record

ArticleNature structural & molecular biology2010

Cooperative interaction of transcription termination factors with the RNA polymerase II C-terminal domain.

Bradley M Lunde, Steve L Reichow, Minkyu Kim, Hyunsuk Suh, Thomas C Leeper, Fan Yang, Hannes Mutschler, Stephen Buratowski, Anton Meinhart, Gabriele Varani

Open access · greenAbstract readComparative Study
In one paragraph

Article in Nature structural & molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 155 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Toward structural understanding of eukaryotic transcription elongation.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Bradley M LundeDepartment of Biochemistry, University of Washington, Seattle, Washington, USA.
Steve L Reichow
Minkyu Kim
Hyunsuk Suh
Thomas C Leeper
Fan Yang
Hannes Mutschler
Stephen Buratowski
Anton Meinhart
Gabriele Varani
Seattle University · USHarvard University · USMax Planck Society · DEMax Planck Institute for Medical Research · DESeoul National University · KRUniversity of Washington · US

Funding

The RNA Polymerase II Transcription CycleR01GM056663 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Stephen Buratowski · 1999 to 2026
$11.7M
Specificity of mRNA 3'-end processing and transcription terminationR01GM064440 · NIGMS · UNIVERSITY OF WASHINGTON · PI VARANI, GABRIELE · 2002 to 2015
$4.5M
NIGMS NIH HHS GM56663NIGMS NIH HHS GM64440NIGMS NIH HHS R01 GM056663NIGMS NIH HHS R01 GM064440
6 · The paper itself

Abstract

Phosphorylation of the C-terminal domain (CTD) of RNA polymerase II controls the co-transcriptional assembly of RNA processing and transcription factors. Recruitment relies on conserved CTD-interacting domains (CIDs) that recognize different CTD phosphoisoforms during the transcription cycle, but the molecular basis for their specificity remains unclear. We show that the CIDs of two transcription termination factors, Rtt103 and Pcf11, achieve high affinity and specificity both by specifically recognizing the phosphorylated CTD and by cooperatively binding to neighboring CTD repeats. Single-residue mutations at the protein-protein interface abolish cooperativity and affect recruitment at the 3' end processing site in vivo. We suggest that this cooperativity provides a signal-response mechanism to ensure that its action is confined only to proper polyadenylation sites where Ser2 phosphorylation density is highest.

Indexed as

Amino Acid SequenceConserved SequenceHumansModels, MolecularMolecular Sequence DatamRNA Cleavage and Polyadenylation FactorsNuclear ProteinsPeptide FragmentsPhosphorylationPhosphoserinePoint MutationProtein ConformationProtein Interaction MappingProtein Processing, Post-TranslationalProtein Structure, TertiaryRNA-Binding ProteinsmRNA Cleavage and Polyadenylation FactorsNRD1 protein, S cerevisiaeNuclear ProteinsPCF11 protein, S cerevisiaePeptide FragmentsPhosphoserineRNA-Binding ProteinsRNA Polymerase IIRtt103 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSCAF8 protein, humanSerine-Arginine Splicing FactorsTranscription Factors

Identifiers

PMID20818393
PMCPMC2950884
OpenAlexW2078525643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.